Loading company…
Prolexys Pharmaceuticals develops biopharmaceutical treatments for disease areas.
Prolexys Pharmaceuticals develops biopharmaceutical treatments and conducts related research and development. Founded in 2001, it is based in Salt Lake City, US. In November 2008, it raised USD 20 mn in Series A funding led by New Venturetec.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in